Structure based on 2amq |
Ideal structure |
|
| Name: n-[(5-methylisoxazol-3-yl)carbonyl]alanyl-l-valyl-n~1~-((1r,2z)-4-(benzyloxy)-4-oxo-1-{[(3r)-2-oxopyrrolidin-3-yl]methyl}but-2-enyl)-l-leucinamide |
| Formula: C35 H48 N6 O8 |
| Weight: 680.791 |
| SMILES: "CC(C)C[CH](NC(=O)[CH](NC(=O)[CH](C)NC(=O)c1cc(C)on1)C(C)C)C(=O)N[CH](C[CH]2CCNC2=O)C=CC(=O)OCc3ccccc3" |
| Spacial conformation based on PDB
2amq |
RESIDUE 3IH 97
CONECT N1 2 C1 O1
CONECT C1 3 N1 C2 C4
CONECT C2 3 C1 C3 H2
CONECT C3 3 C2 O1 C35
CONECT O1 2 N1 C3
CONECT C4 3 C1 O2 N2
CONECT O2 1 C4
CONECT N2 3 C4 C5 HN2
CONECT C5 4 N2 C6 C7 H5
CONECT C6 4 C5 H61 H62 H63
CONECT C7 3 C5 O3 N3
CONECT O3 1 C7
CONECT N3 3 C7 C8 HN3
CONECT C8 4 N3 C9 C12 H8
CONECT C9 4 C8 C10 C11 H9
CONECT C10 4 C9 H101 H102 H103
CONECT C11 4 C9 H111 H112 H113
CONECT C12 3 C8 O4 N4
CONECT O4 1 C12
CONECT N4 3 C12 C13 HN4
CONECT C13 4 N4 C14 C18 H13
CONECT C14 4 C13 C15 H141 H142
CONECT C15 4 C14 C16 C17 H15
CONECT C16 4 C15 H161 H162 H163
CONECT C17 4 C15 H171 H172 H173
CONECT C19 4 C20 C25 N5 H19
CONECT C20 3 C19 C21 H20
CONECT C21 3 C20 C22 H21
CONECT C22 3 C21 O6 O7
CONECT O6 1 C22
CONECT O7 2 C22 C23
CONECT C23 4 O7 C24 H231 H232
CONECT C24 3 C23 C30 C34
CONECT C25 4 C19 C26 H251 H252
CONECT C26 4 C25 C27 C29 H26
CONECT C27 4 C26 C28 H271 H272
CONECT C28 4 C27 N6 H281 H282
CONECT N6 3 C28 C29 HN6
CONECT C29 3 C26 N6 O8
CONECT O8 1 C29
CONECT C30 3 C24 C31 H30
CONECT C31 3 C30 C32 H31
CONECT C32 3 C31 C33 H32
CONECT C33 3 C32 C34 H33
CONECT C34 3 C24 C33 H34
CONECT C35 4 C3 H351 H352 H353
CONECT C18 3 C13 O5 N5
CONECT O5 1 C18
CONECT N5 3 C19 C18 HN5
CONECT H2 1 C2
CONECT HN2 1 N2
CONECT H5 1 C5
CONECT H61 1 C6
CONECT H62 1 C6
CONECT H63 1 C6
CONECT HN3 1 N3
CONECT H8 1 C8
CONECT H9 1 C9
CONECT H101 1 C10
CONECT H102 1 C10
CONECT H103 1 C10
CONECT H111 1 C11
CONECT H112 1 C11
CONECT H113 1 C11
CONECT HN4 1 N4
CONECT H13 1 C13
CONECT H141 1 C14
CONECT H142 1 C14
CONECT H15 1 C15
CONECT H161 1 C16
CONECT H162 1 C16
CONECT H163 1 C16
CONECT H171 1 C17
CONECT H172 1 C17
CONECT H173 1 C17
CONECT H19 1 C19
CONECT H20 1 C20
CONECT H21 1 C21
CONECT H231 1 C23
CONECT H232 1 C23
CONECT H251 1 C25
CONECT H252 1 C25
CONECT H26 1 C26
CONECT H271 1 C27
CONECT H272 1 C27
CONECT H281 1 C28
CONECT H282 1 C28
CONECT HN6 1 N6
CONECT H30 1 C30
CONECT H31 1 C31
CONECT H32 1 C32
CONECT H33 1 C33
CONECT H34 1 C34
CONECT H351 1 C35
CONECT H352 1 C35
CONECT H353 1 C35
CONECT HN5 1 N5
END
HET 3IH 97
HETSYN 3IH (E)-(4S,6S)-8-METHYL-6-((S)-3-METHYL-2-{(S)-2-[(5-METHY
HETSYN 2 3IH L-ISOXAZOLE-3-CARBONYL)-AMINO]-PROPIONYLAMINO}-BUTYRYLA
HETSYN 3 3IH MINO)-5-OXO-4-((R)-2-OXO-PYRROLIDIN-3-YLMETHYL)-NON-2-E
HETSYN 4 3IH NOIC ACID BENZYL ESTER
HETNAM 3IH N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-
HETNAM 2 3IH ((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3
HETNAM 3 3IH -YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE
FORMUL 3IH C35 H48 N6 O8
MONOMER page